INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 186 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $493,000 | -67.7% | 7,830 | -36.5% | 0.05% | -43.2% |
| Q4 2019 | $1,528,000 | -21.6% | 12,329 | -58.0% | 0.09% | -5.4% |
| Q3 2019 | $1,948,000 | -16.8% | 29,354 | -0.2% | 0.09% | -10.6% |
| Q2 2019 | $2,340,000 | -4.3% | 29,409 | +34.5% | 0.10% | +10.6% |
| Q1 2019 | $2,446,000 | +171.8% | 21,870 | +144.9% | 0.09% | +161.1% |
| Q4 2018 | $900,000 | +318.6% | 8,930 | +425.3% | 0.04% | +500.0% |
| Q3 2018 | $215,000 | – | 1,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |